However, the available data suggest that IL-6, CRP, and TNF-α measurements in diabetic foot ulcers could be valuable tools for patient risk stratification, as well as predictors for lower-limb amputation and perioperative risk of morbidity and mortality. This evidence concerns the gene TNF and diabetic foot.